Psoriasis may raise risk of Sjögren’s by 50%, large study finds

People with psoriasis, an autoimmune disorder marked by itchy, red patches of skin, appear to have a 50% increased risk of developing Sjögren’s syndrome, according to an analysis of medical records involving nearly 600,000 people. The risk of developing Sjögren’s was even higher…

Orencia Fails to Reduce Disease Activity in Patients with Early Active Primary Sjögren’s Syndrome, Trial Shows

Orencia (abatacept), an immunotherapy used in rheumatic diseases, failed to reduce disease activity in patients with early active primary Sjögren’s syndrome after 24 weeks of treatment, results from the ASAPIII Phase 3 trial show. However, more patients reported an easing of disease symptoms while taking Orencia, compared…